Morgan Stanley Reiterates Overweight on Edwards Lifesciences, Maintains $102 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood has reiterated an Overweight rating on Edwards Lifesciences (NYSE:EW) and maintained a price target of $102.
July 27, 2023 | 4:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has reiterated an Overweight rating on Edwards Lifesciences and maintained a price target of $102.
The reiteration of an Overweight rating by Morgan Stanley indicates a positive outlook for Edwards Lifesciences. The maintained price target of $102 suggests that the analyst believes the stock is still undervalued, which could lead to upward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100